Virax Biolabs Group Ltd

VRAX chart

Virax Biolabs Group Ltd news

• Virax Biolabs Group Ltd (VRAX-Q) Stock Price and News

  The Globe and Mail · Oct 27, 5:32 AM EDT

• Virax Biolabs Group Limited Estimates – NASDAQ:VRAX

  TradingView · Oct 24, 8:22 AM EDT

• 12 Health Care Stocks Moving In Thursday's Pre-Market Session

  Benzinga · Oct 22, 8:05 AM EDT

• Five option grants held by Clement Monteil expire from 2032 to 2036 at Virax Biolabs (VRAX).

  Stock Titan · Oct 21, 8:12 AM EDT

• Join Virax's Live Investor Webinar: Advancing Immune Diagnostics, Clinical Development and Commercial Execution

  Yahoo Finance · Aug 20, 10:00 AM EDT

• Virax Biolabs and Transcode Therapeutics Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV

  Yahoo Finance · Aug 7, 9:00 AM EDT

• Alliance Entertainment and Virax Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

  Yahoo Finance · Jul 20, 9:00 AM EDT

• Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement

  Yahoo Finance · Jul 16, 7:30 AM EDT

• Virax Biolabs enters immune profiling product supply deal with Fosun

  hospitalmanagement.net · Jul 13, 5:48 AM EDT

• Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds

  Yahoo Finance · Jul 10, 4:05 PM EDT

• Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds

  Yahoo Finance · Jul 9, 1:35 PM EDT

• Why Did Virax Biolabs Stock Triple In One Session?

  Yahoo Finance · Jul 9, 10:31 AM EDT

Virax Biolabs Group Ltd key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-K6-K2026-10-09
• 6-K6-K2026-09-04
• 6-K6-K2026-08-26
• 6-K6-K2026-08-18
• 6-K6-K2026-07-31
• 6-K6-K2026-07-16
• 6-K6-K2026-07-10
• 6-K6-K2026-07-09
• 20-F20-F2026-07-06
• 6-K6-K2026-06-24
• 6-K6-K2026-06-12
• 6-K6-K2026-05-26

About Virax Biolabs Group Ltd

Ticker

VRAX (Nasdaq)

Industry

In Vitro & In Vivo Diagnostic Substances

Headquarters

Lanarkshire, United Kingdom

Incorporated in

Cayman Islands

Fiscal year end

March 31

SEC CIK

1885827

Former names

Virax Biolabs (Cayman) Ltd

Frequently asked questions